[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB9900413D0 - Inhibitors - Google Patents

Inhibitors

Info

Publication number
GB9900413D0
GB9900413D0 GBGB9900413.7A GB9900413A GB9900413D0 GB 9900413 D0 GB9900413 D0 GB 9900413D0 GB 9900413 A GB9900413 A GB 9900413A GB 9900413 D0 GB9900413 D0 GB 9900413D0
Authority
GB
United Kingdom
Prior art keywords
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9900413.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alizyme Therapeutics Ltd
Original Assignee
Alizyme Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alizyme Therapeutics Ltd filed Critical Alizyme Therapeutics Ltd
Priority to GBGB9900413.7A priority Critical patent/GB9900413D0/en
Publication of GB9900413D0 publication Critical patent/GB9900413D0/en
Priority to ARP000100030A priority patent/AR022204A1/en
Priority to EP00900082A priority patent/EP1143977B3/en
Priority to RU2001123171/04A priority patent/RU2245331C2/en
Priority to KR1020017008576A priority patent/KR100678998B1/en
Priority to SI200030683T priority patent/SI1143977T1/xx
Priority to CNB008036225A priority patent/CN1315813C/en
Priority to CA002359819A priority patent/CA2359819C/en
Priority to AT00900082T priority patent/ATE293447T1/en
Priority to CN2005101250838A priority patent/CN1915981B/en
Priority to MYPI20000057A priority patent/MY122578A/en
Priority to NZ512740A priority patent/NZ512740A/en
Priority to CH00900082T priority patent/CH1143977H1/en
Priority to DE60019555T priority patent/DE60019555C5/en
Priority to PT00900082T priority patent/PT1143977E/en
Priority to PL385853A priority patent/PL207383B1/en
Priority to DK00900082T priority patent/DK1143977T3/en
Priority to MXPA01006921A priority patent/MXPA01006921A/en
Priority to ES00900082T priority patent/ES2240052T7/en
Priority to AU18846/00A priority patent/AU765147C/en
Priority to HU0105003A priority patent/HUP0105003A3/en
Priority to JP2000592004A priority patent/JP3822439B2/en
Priority to PCT/GB2000/000032 priority patent/WO2000040247A1/en
Priority to US09/901,887 priority patent/US6624161B2/en
Priority to NO20013381A priority patent/NO333922B1/en
Priority to US10/306,377 priority patent/US7825113B2/en
Priority to HK02109053.3A priority patent/HK1047588B/en
Priority to HK07108198.6A priority patent/HK1103928A1/en
Priority to US12/044,318 priority patent/US7858617B2/en
Priority to US12/952,972 priority patent/US8877750B2/en
Ceased legal-status Critical Current

Links

GBGB9900413.7A 1999-01-08 1999-01-08 Inhibitors Ceased GB9900413D0 (en)

Priority Applications (30)

Application Number Priority Date Filing Date Title
GBGB9900413.7A GB9900413D0 (en) 1999-01-08 1999-01-08 Inhibitors
ARP000100030A AR022204A1 (en) 1999-01-08 2000-01-05 COMPOUND, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION AND EDIBLE PRODUCT THAT UNDERSTANDS IT.
PCT/GB2000/000032 WO2000040247A1 (en) 1999-01-08 2000-01-06 2-oxy-benzoxazinone derivatives for the treatment of obesity
PT00900082T PT1143977E (en) 1999-01-08 2000-01-06 2-OXIBENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF OBESITY
MXPA01006921A MXPA01006921A (en) 1999-01-08 2000-01-06 2-amino-4h-3,1-benzoxazin-4-one derivatives for the treatment of obesity.
KR1020017008576A KR100678998B1 (en) 1999-01-08 2000-01-06 2-oxy-4h-3,1-benzoxazin-4-ones for treatment of obesity
SI200030683T SI1143977T1 (en) 1999-01-08 2000-01-06
CNB008036225A CN1315813C (en) 1999-01-08 2000-01-06 2-oxy-benzoxazine derivatives for the treatment of obesity
CA002359819A CA2359819C (en) 1999-01-08 2000-01-06 2-oxy-benzoxazinone derivatives for the treatment of obesity
AT00900082T ATE293447T1 (en) 1999-01-08 2000-01-06 2-OXY-BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF OBESITY
CN2005101250838A CN1915981B (en) 1999-01-08 2000-01-06 2-oxy-benzoxazinone derivatives for the treatment of obesity
MYPI20000057A MY122578A (en) 1999-01-08 2000-01-06 2-oxy-benzoxazinone derivatives for the treatment of obesity
NZ512740A NZ512740A (en) 1999-01-08 2000-01-06 2-oxy-benzoxazinone derivatives for the treatment of obesity
CH00900082T CH1143977H1 (en) 1999-01-08 2000-01-06 2-Oxy-benzoxazine-4-ones for the treatment of obesity
DE60019555T DE60019555C5 (en) 1999-01-08 2000-01-06 2-OXY-BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
EP00900082A EP1143977B3 (en) 1999-01-08 2000-01-06 2-oxy-benzoxazinone derivatives for the treatment of obesity
PL385853A PL207383B1 (en) 1999-01-08 2000-01-06 The use of 2-oxy-4H-3, 1-benzoxazin-4-on derivatives
DK00900082T DK1143977T3 (en) 1999-01-08 2000-01-06 2-oxy-benzoxazinone derivatives for the treatment of obesity
RU2001123171/04A RU2245331C2 (en) 1999-01-08 2000-01-06 Derivatives of 2-oxy-4h-3,1-benzoxazine-2-one for prophylaxis and/or treatment of obesity or accompanying disorder
ES00900082T ES2240052T7 (en) 1999-01-08 2000-01-06 2-Oxy benzoxazinone derivatives for the treatment of obesity
AU18846/00A AU765147C (en) 1999-01-08 2000-01-06 2-Oxy-4H-3,1-Benzoxazin-4-Ones for the treatment of obesity
HU0105003A HUP0105003A3 (en) 1999-01-08 2000-01-06 2-oxy-4h-3,1-benzoxazin-4-one derivatives, their use and pharmaceutical compositions containing them
JP2000592004A JP3822439B2 (en) 1999-01-08 2000-01-06 2-Oxy-4H-3,1-benzoxazin-4-one for the treatment of obesity
NO20013381A NO333922B1 (en) 1999-01-08 2001-07-06 2-oxybenzoxazinone derivatives, process for preparation, use thereof for the manufacture of a medicament for the treatment of obesity, and pharmaceutical composition and food product comprising the compound
US09/901,887 US6624161B2 (en) 1999-01-08 2001-07-06 2-Oxy-benzoxazinone derivatives for the treatment of obesity
US10/306,377 US7825113B2 (en) 1999-01-08 2002-11-27 2-oxy-benzoxazinone derivatives for the treatment of obesity
HK02109053.3A HK1047588B (en) 1999-01-08 2002-12-13 2-oxy-4h-3,1-benzoxazine-4-one derivatives for the treatment of obesity
HK07108198.6A HK1103928A1 (en) 1999-01-08 2007-07-27 2-oxy-4h-3,1-benzoxazin-4-ones for treatment of obesity
US12/044,318 US7858617B2 (en) 1999-01-08 2008-03-07 2-oxy-benzoxazinone derivatives for the treatment of obesity
US12/952,972 US8877750B2 (en) 1999-01-08 2010-11-23 2-oxy-benzoxazinone derivatives for the treatment of obesity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9900413.7A GB9900413D0 (en) 1999-01-08 1999-01-08 Inhibitors

Publications (1)

Publication Number Publication Date
GB9900413D0 true GB9900413D0 (en) 1999-02-24

Family

ID=10845775

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9900413.7A Ceased GB9900413D0 (en) 1999-01-08 1999-01-08 Inhibitors

Country Status (1)

Country Link
GB (1) GB9900413D0 (en)

Similar Documents

Publication Publication Date Title
GB9900416D0 (en) Inhibitors
GB9912961D0 (en) Metalloprotease inhibitors
EG23979A (en) Renin inhibitors
IL148820A0 (en) Fab i inhibitors
IL145085A0 (en) Dihetero-substituted metalloprotease inhibitors
HK1042695A1 (en) Prothease inhibitors
EP1235577A4 (en) Protease inhibitors
GB9924522D0 (en) Enzyme inhibitors
EP1232155A4 (en) Protease inhibitors
EP1229912A4 (en) Protease inhibitors
EP1231921A4 (en) Protease inhibitors
EP1229915A4 (en) Protease inhibitors
EP1229914A4 (en) Protease inhibitors
HK1043534A1 (en) Protease inhibitors
EP1173429A4 (en) Protease inhibitors
EP1229911A4 (en) Protease inhibitors
EP1351930A4 (en) Protease inhibitors
EP1233771A4 (en) Protease inhibitors
GB2389113B (en) B-secretase inhibitor
EP1231923A4 (en) Protease inhibitors
EP1232154A4 (en) Protease inhibitors
EP1231922A4 (en) Protease inhibitors
EP1189618A4 (en) Thrombin inhibitors
GB9929341D0 (en) Inhibitors
GB9900413D0 (en) Inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)